Emergent Biosolutions Net Worth

Emergent Biosolutions Net Worth Analysis

Emergent Biosolutions Target Price Consensus

Emergent Biosolutions Target Price Projection

Emergent Biosolutions' current and average target prices are 5.72 and 12.00, respectively. The current price of Emergent Biosolutions is the price at which Emergent Biosolutions is currently trading. On the other hand, Emergent Biosolutions' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Emergent Biosolutions and the information provided on this page.

Know Emergent Biosolutions' Top Institutional Investors

Note, although Emergent Biosolutions' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Emergent Biosolutions' market capitalization trends

The company currently falls under 'Small-Cap' category with a total capitalization of 540.22 M.

Project Emergent Biosolutions' profitablity

The company has Net Profit Margin of (0.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.25 %, which entails that for every 100 dollars of revenue, it generated $0.25 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Emergent Biosolutions' management efficiency

Emergent Biosolutions has Return on Asset of (0.0422) % which means that on every $100 spent on assets, it lost $0.0422. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3464) %, meaning that it generated no profit with money invested by stockholders. Emergent Biosolutions' management efficiency ratios could be used to measure how well Emergent Biosolutions manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.2 in 2025. Return On Capital Employed is likely to gain to -0.08 in 2025. At this time, Emergent Biosolutions' Non Current Assets Total are comparatively stable compared to the past year. Other Assets is likely to gain to about 231 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 18 M in 2025.

Emergent Biosolutions Corporate Filings

Emergent Biosolutions time-series forecasting models is one of many Emergent Biosolutions' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Emergent Biosolutions' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Emergent Biosolutions Earnings Estimation Breakdown

The calculation of Emergent Biosolutions' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Emergent Biosolutions is estimated to be 1.5 with the future projection ranging from a low of 1.5 to a high of 1.5. Please be aware that this consensus of annual earnings estimates for Emergent Biosolutions is based on EPS before non-recurring items and includes expenses related to employee stock options.

Emergent Biosolutions Earnings Projection Consensus

Emergent Biosolutions Earnings per Share Projection vs Actual

Actual Earning per Share of Emergent Biosolutions refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Emergent Biosolutions predict the company's earnings will be in the future. The higher the earnings per share of Emergent Biosolutions, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Emergent Biosolutions Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Emergent Biosolutions, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Emergent Biosolutions should always be considered in relation to other companies to make a more educated investment decision.

Emergent Quarterly Analyst Estimates and Surprise Metrics

Emergent Biosolutions Corporate Directors

Additional Tools for Emergent Stock Analysis